A systematic review of the international prevalence of BRCA mutation in breast cancer
N Armstrong, S Ryder, C Forbes, J Ross… - Clinical …, 2019 - Taylor & Francis
A systematic review was conducted, summarizing international BRCA 1 or 2 (BRCA1/2)
mutation prevalence in breast cancer. Databases (eg, Medline and Embase; N= 7) and …
mutation prevalence in breast cancer. Databases (eg, Medline and Embase; N= 7) and …
The role of risk-reducing surgery in hereditary breast and ovarian cancer
LC Hartmann, NM Lindor - New England Journal of Medicine, 2016 - Mass Medical Soc
The risk of breast and ovarian cancer among women with mutations such as BRCA1 and
BRCA2 mutations can be mitigated by operations to remove the organs at greatest risk. Data …
BRCA2 mutations can be mitigated by operations to remove the organs at greatest risk. Data …
[PDF][PDF] 中国女性乳腺癌筛查与早诊早治指南(2021, 北京)
赫捷， 陈万青， 李霓， 沈洪兵， 李江， 王勇， 李静… - 中国 …, 2021 - medi-guide.meditool.cn
乳腺癌是中国女性最常见的恶性肿瘤, 发病率位居中国女性恶性肿瘤首位. 国家癌症中心受国家
卫生健康委员会疾病预防控制局委托, 根据《 世界卫生组织指南制定手册》 …
卫生健康委员会疾病预防控制局委托, 根据《 世界卫生组织指南制定手册》 …
Breast cancer screening for women at average risk: 2015 guideline update from the American Cancer Society
KC Oeffinger, ETH Fontham, R Etzioni, A Herzig… - Jama, 2015 - jamanetwork.com
Importance Breast cancer is a leading cause of premature mortality among US women. Early
detection has been shown to be associated with reduced breast cancer morbidity and …
detection has been shown to be associated with reduced breast cancer morbidity and …
Consensus guidelines on genetictesting for hereditary breast cancer from the American Society of Breast Surgeons
ER Manahan, HM Kuerer, M Sebastian… - Annals of surgical …, 2019 - Springer
Background The purpose of this consensus guideline is to outline recommendations for
genetic testing that medical professionals can use to assess hereditary risk for breast …
genetic testing that medical professionals can use to assess hereditary risk for breast …
[HTML][HTML] Diagnosis and management of ovarian cancer
CA Doubeni, ARB Doubeni, AE Myers - American family physician, 2016 - aafp.org
Ovarian cancer is the fifth-leading cause of cancer-related death in women. The strongest
known risk factors are familial genetic syndromes, such as BRCA gene mutations and …
known risk factors are familial genetic syndromes, such as BRCA gene mutations and …
Clinical actionability of multigene panel testing for hereditary breast and ovarian cancer risk assessment
A Desmond, AW Kurian, M Gabree, MA Mills… - JAMA …, 2015 - jamanetwork.com
Importance The practice of genetic testing for hereditary breast and/or ovarian cancer
(HBOC) is rapidly evolving owing to the recent introduction of multigene panels. While these …
(HBOC) is rapidly evolving owing to the recent introduction of multigene panels. While these …
Racial disparities in BRCA testing and cancer risk management across a population‐based sample of young breast cancer survivors
D Cragun, A Weidner, C Lewis, D Bonner, J Kim… - Cancer, 2017 - Wiley Online Library
BACKGROUND Breast cancer (BC) disparities may widen with genomic advances. The
authors compared non‐Hispanic white (NHW), black, and Hispanic BC survivors for 1) …
authors compared non‐Hispanic white (NHW), black, and Hispanic BC survivors for 1) …
Identification of a variety of mutations in cancer predisposition genes in patients with suspected Lynch syndrome
MB Yurgelun, B Allen, RR Kaldate, KR Bowles… - Gastroenterology, 2015 - Elsevier
Background & Aims Multigene panels are commercially available tools for hereditary cancer
risk assessment that allow for next-generation sequencing of numerous genes in parallel …
risk assessment that allow for next-generation sequencing of numerous genes in parallel …
[HTML][HTML] Points to consider: ethical, legal, and psychosocial implications of genetic testing in children and adolescents
In 1995, the American Society of Human Genetics (ASHG) and American College of Medical
Genetics and Genomics (ACMG) jointly published a statement on genetic testing in children …
Genetics and Genomics (ACMG) jointly published a statement on genetic testing in children …